Aspira Women's Health Inc...

0.10
0.00 (2.99%)
At close: Apr 14, 2025, 3:59 PM
0.09
-0.11%
After-hours: Apr 14, 2025, 07:22 PM EDT
2.99%
Bid 0.09
Market Cap 1.68M
Revenue (ttm) 9.18M
Net Income (ttm) -13.09M
EPS (ttm) -0.93
PE Ratio (ttm) -0.1
Forward PE -0.82
Analyst Buy
Ask 0.1
Volume 576,340
Avg. Volume (20D) 4,608,395
Open 0.10
Previous Close 0.10
Day's Range 0.09 - 0.10
52-Week Range 0.08 - 3.63
Beta 2.01

About AWH

Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service fo...

Sector Healthcare
IPO Date Oct 2, 2000
Employees 66
Stock Exchange NASDAQ
Ticker Symbol AWH
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for AWH stock is "Buy." The 12-month stock price forecast is $5.5, which is an increase of 5683.39% from the latest price.

Stock Forecasts

Next Earnings Release

Aspira Women's Health Inc. is scheduled to release its earnings on May 14, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-11.62%
Aspira Women's Health shares are trading higher af... Unlock content with Pro Subscription
9 months ago
+7.63%
Aspira Women's Health shares are trading higher after the company announced that preliminary OvaWatch volume during Q2 2024 grew 24% quarter-over-quarter to 1,307 units.